Marathon Capital Management Enzo Biochem Inc Transaction History

Marathon Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.82 - $3.87 $60,933 - $129,567	-33,480 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $411,457 - $589,168	-160,100 Reduced 82.7%	33,480 $88,000
Q3 2019 Nov 13, 2019	SELL	$3.01 - $4.0 $161,185 - $214,200	-53,550 Reduced 21.67%	193,580 $697,000
Q2 2019 Jul 25, 2019	SELL	$2.79 - $4.31 $320,197 - $494,641	-114,766 Reduced 31.71%	247,130 $832,000
Q1 2019 May 15, 2019	BUY	$2.54 - $4.02 $75,819 - $119,996	29,850 Added 8.99%	361,896 $987,000
Q4 2018 Feb 07, 2019	SELL	$2.46 - $4.2 $179,580 - $306,600	-73,000 Reduced 18.02%	332,046 $923,000
Q3 2018 Nov 13, 2018	BUY	$3.81 - $5.53 $183,802 - $266,778	48,242 Added 13.52%	405,046 $1.67 Million
Q2 2018 Aug 07, 2018	BUY	$5.06 - $6.78 $62,743 - $84,072	12,400 Added 3.6%	356,804 $1.85 Million
Q1 2018 May 07, 2018	BUY	$5.43 - $8.36 $472,165 - $726,943	86,955 Added 33.78%	344,404 $1.89 Million
Q4 2017 Feb 13, 2018	BUY	$8.15 - $10.55 $42,575 - $55,113	5,224 Added 2.07%	257,449 $2.1 Million
Q3 2017 Nov 13, 2017	BUY	$10.45 - $11.44 $2.64 Million - $2.89 Million	252,225	252,225 $2.64 Million

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Marathon Capital Management with notifications on news.